Previous Article | Next Article ![]()
J. Virol., 02 1997, 1397-1404, Vol 71, No. 2
DS An, Y Koyanagi, JQ Zhao, R Akkina, G Bristol, N Yamamoto, JA Zack and IS Chen
Gene therapy strategies for humans have been limited by low transduction
efficiencies and poor expression of retroviral vectors in differentiated
progeny cells carrying the transduced vector. Here we describe a strategy
utilizing a cell surface reporter gene, murine thy- 1.2, selectable by
fluorescence-activated cell sorting (FACS), to achieve higher gene marking
efficiencies. Human CD34-positive cells were transduced by a murine
retroviral vector bearing the thy-1.2 marker and pseudotyped with vesicular
stomatitis virus G protein, followed by FACS to enrich for CD34-positive
cells that express Thy-1.2 on the cell surface. Gene marking and expression
after differentiation into thymocytes were assessed in a SCID-hu Thy/Liv
mouse model for human lymphoid progenitor cell gene therapy. We found that
virtually all of the differentiated T-cell progeny were marked with vector
sequences. It is of particular importance that reconstitution with the
selected cells resulted in expression of Thy-1.2 in up to 71% of donor-
derived thymocytes. It is of note that the donor-derived thymocytes that
did not express Thy-1.2 still harbored vector thy-1.2 sequences, suggesting
repression of transgene expression in some cells during progenitor cell
differentiation into thymocytes. These studies provide a proof of concept
for efficient expression of transgenes through T- lymphoid differentiation
and a potential basis for utilizing similar strategies in human gene
therapy clinical trials.
Copyright © 1997, American Society for Microbiology
High-efficiency transduction of human lymphoid progenitor cells and expression in differentiated T cells
Department of Microbiology & Immunology, UCLA School of Medicine, Los Angeles, California 90095-1678, USA.
This article has been cited by other articles:
| J. Bacteriol. | Mol. Cell. Biol. | Microbiol. Mol. Biol. Rev. |
|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|